Navigation Links
Empire BlueCross BlueShield Expands Lab Networks -- Creating Broader Choice, Robust Competition and Lower Costs for Consumers

NEW YORK, Aug. 2 /PRNewswire/ -- Empire BlueCross BlueShield, New York's largest insurer by medical membership, announced today that, effective August 1, 2010, it will significantly expand its HMO and PPO/EPO & Indemnity Reference Laboratory Networks.  This expansion ensures broader choices for members and physicians, creates an environment in which labs compete on service, quality and choice, and reduces the need for members to spend more of their health care dollars using out-of-network laboratories.

Specifically, Empire is:  

  • Expanding its HMO Reference Laboratory Network to include Laboratory Corporation of America® Holdings (LabCorp®), DIANON Systems and Centrex Clinical Labs (both LabCorp subsidiaries) for all markets.  In addition, for the areas of Brooklyn and Queens, Shiel Medical Laboratory will also be added.

  • Expanding its PPO/EPO and Indemnity Reference Laboratory Network to include Laboratory Corporation of America Holdings (LabCorp), DIANON Systems, Centrex Clinical Labs, BioReference Laboratories, Inc., Enzo Clinical Laboratories, and Sunrise Medical Laboratories.

In addition to patient service centers, these labs offer courier pick-up services for specimens collected in provider offices, offering another convenient option to Empire members.

"With the addition of these new laboratory partners, Empire now has an unsurpassed laboratory network," said Mark Wagar, president and CEO of Empire BlueCross BlueShield.  "This broad network enables our 6 million members to choose to use the reference lab that best meets their needs based on quality, service and cost."

For a complete list of providers participating in Empire's reference laboratory networks, members can visit or contact the Provider Services Department at 800-552-6630.

Empire BlueCross BlueShield

Empire BlueCross BlueShield (Empire) is the trade name of Empire HealthChoice Assurance, Inc., and Empire Blue Cross Blue Shield HMO is the trade name of Empire HealthChoice HMO, Inc., independent licensees of the Blue Cross Blue Shield Association, serving residents and businesses in the 28 eastern and southeastern counties of New York State.  Additional information about Empire is available at

SOURCE Empire BlueCross BlueShield
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Regence BlueCross BlueShield Wins Peoples Voice Award for Online Consumer Campaign in the 14th Annual Webby Awards
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
4. Cellectar Expands Clinical Management Team
5. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
8. PAREXEL Expands Global Clinical Pharmacology Capabilities
9. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
10. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
11. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Post Your Comments:
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... November 26, 2015 Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Research . --> Clinical Cancer Research . ...
(Date:11/26/2015)... 26, 2015 --> ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... found that immunotherapy can be efficiently combined with photodynamic ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the health care in America. As people age, more care is needed, especially ... are rising, and medical professionals are being overworked. The forgotten part of this ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the November 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, ... of 750,000. The digital component is distributed nationally, through a vast social media ...
(Date:11/27/2015)... ... 27, 2015 , ... A simply groundbreaking television series, "Voices in America", which ... into an array of issues that are presently affecting Americans. Dedicated to providing the ... show is changing the subjects consumers focus on, one episode at a time. ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... ... California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at ... They observed that both STEMI and Sepsis conditions present in similar ways and require ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
Breaking Medicine News(10 mins):